Growth Hormone Secretion
MK-677
Ibutamoren; MK-0677; L-163191
Classification: Oral non-peptide ghrelin receptor agonist
Mechanism: GHS-R1a agonist; stimulates pulsatile GH/IGF-1 release; orally bioavailable spiropiperidine
Benefits: Increased GH/IGF-1; improved sleep; lean mass; bone density
Evidence tier: Phase 3 (not approved) · Availability: Research Chemical
Primary sources
Loading interactive view…